505 — Asiamedic Cashflow Statement
0.000.00%
Last trade - 00:00- SG$11.55m
- SG$11.39m
- SG$23.51m
- 36
- 84
- 41
- 55
Annual cashflow statement for Asiamedic, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.588 | -4.3 | 0.715 | 2.19 | 1.03 |
| Depreciation | |||||
| Non-Cash Items | -0.083 | 3.54 | 0.628 | -1.21 | -0.277 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.73 | 0.425 | 0.826 | -0.785 | 0.589 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.09 | 2.33 | 3.44 | 1.23 | 3.41 |
| Capital Expenditures | -0.172 | -0.35 | -0.379 | -0.999 | -3.93 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.403 | 0.493 | 0.32 | -1.65 | -2.43 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.231 | 0.144 | -0.058 | -2.65 | -6.37 |
| Financing Cash Flow Items | -0.402 | 3.37 | -0.143 | -0.332 | -0.072 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.378 | 2.29 | -1.56 | -1.41 | 0.915 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.057 | 4.77 | 1.82 | -2.83 | -2.04 |